Crossmark Global Holdings’s Neurocrine Biosciences NBIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.01M | Sell |
8,022
-763
| -9% | -$95.9K | 0.02% | 605 |
|
|
2025
Q1 | $972K | Buy |
8,785
+320
| +4% | +$35.4K | 0.02% | 615 |
|
|
2024
Q4 | $1.16M | Sell |
8,465
-22
| -0.3% | -$3K | 0.02% | 542 |
|
|
2024
Q3 | $978K | Buy |
8,487
+1,204
| +17% | +$139K | 0.02% | 620 |
|
|
2024
Q2 | $1M | Sell |
7,283
-657
| -8% | -$90.5K | 0.02% | 587 |
|
|
2024
Q1 | $1.1M | Sell |
7,940
-116
| -1% | -$16K | 0.02% | 588 |
|
|
2023
Q4 | $1.06M | Sell |
8,056
-491
| -6% | -$64.7K | 0.02% | 577 |
|
|
2023
Q3 | $977K | Sell |
8,547
-489
| -5% | -$55.9K | 0.02% | 577 |
|
|
2023
Q2 | $929K | Sell |
9,036
-379
| -4% | -$39K | 0.02% | 612 |
|
|
2023
Q1 | $953K | Buy |
9,415
+212
| +2% | +$21.5K | 0.02% | 596 |
|
|
2022
Q4 | $1.1M | Sell |
9,203
-83
| -0.9% | -$9.91K | 0.03% | 544 |
|
|
2022
Q3 | $986K | Sell |
9,286
-105
| -1% | -$11.1K | 0.03% | 549 |
|
|
2022
Q2 | $916K | Sell |
9,391
-100
| -1% | -$9.75K | 0.02% | 596 |
|
|
2022
Q1 | $890K | Sell |
9,491
-10
| -0.1% | -$938 | 0.02% | 670 |
|
|
2021
Q4 | $809K | Sell |
9,501
-980
| -9% | -$83.4K | 0.02% | 702 |
|
|
2021
Q3 | $1.01M | Sell |
10,481
-90
| -0.9% | -$8.63K | 0.02% | 612 |
|
|
2021
Q2 | $1.03M | Buy |
+10,571
| New | +$1.03M | 0.02% | 604 |
|
|
2018
Q4 | – | Sell |
-2,496
| Closed | -$307K | – | 1497 |
|
|
2018
Q3 | $307K | Sell |
2,496
-220
| -8% | -$27.1K | 0.01% | 1302 |
|
|
2018
Q2 | $267K | Sell |
2,716
-370
| -12% | -$36.4K | 0.01% | 1387 |
|
|
2018
Q1 | $256K | Sell |
3,086
-1,066
| -26% | -$88.4K | 0.01% | 1370 |
|
|
2017
Q4 | $322K | Sell |
4,152
-514
| -11% | -$39.9K | 0.01% | 1330 |
|
|
2017
Q3 | $286K | Buy |
+4,666
| New | +$286K | 0.01% | 1349 |
|
|
2016
Q3 | $286K | Buy |
+4,666
| New | +$286K | 0.01% | 1349 |
|